These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 12491825)

  • 1. [Hypercoagulability in atrial fibrillation and its relationship with risk factors for systemic embolism].
    Pérez LA; Corbalán R; Acevedo M; Pereira J; Braun S; Tapia J; Kramer A; Lira MT; Huete I; Sepúlveda G; Springmüller D
    Rev Med Chil; 2002 Oct; 130(10):1087-94. PubMed ID: 12491825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Significance of atrial fibrillation, left atrial thrombus and severity of stenosis for risk of systemic embolism in patients with mitral stenosis].
    Sanada J; Komaki S; Sannou K; Tokiwa F; Kodera K; Terada H; Harubyu N; Tanaka Y; Arima T
    J Cardiol; 1999 Jan; 33(1):1-5. PubMed ID: 10028455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between control of ventricular rate in atrial fibrillation and systemic coagulation activation in patients with mitral stenosis.
    Atak R; Turhan H; Senen K; Yalta K; Ayaz S; Alyan O; Basar N; Demirkan D
    J Heart Valve Dis; 2004 Mar; 13(2):159-64. PubMed ID: 15086252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-reactive protein and atrial fibrillation: "evidence for the presence of inflammation in the perpetuation of the arrhythmia".
    Acevedo M; Corbalán R; Braun S; Pereira J; Navarrete C; Gonzalez I
    Int J Cardiol; 2006 Apr; 108(3):326-31. PubMed ID: 15985301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypercoagulability and chronic atrial fibrillation: the role of markers of thrombin generation.
    Soncini M; Casazza F; Mattioli R; Bonfardeci C; Motta A; Cimminiello C
    Minerva Med; 1997 Dec; 88(12):501-5. PubMed ID: 9540779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cardiac rhythm and systemic embolism in long-term follow up of patients with non-valvular paroxysmal atrial fibrillation].
    Bugueño C; Corbalán R; Braun S; Tapia J; Kramer A; Huete I; Chávez A
    Rev Med Chil; 1998 Jun; 126(6):646-54. PubMed ID: 9778872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute onset human atrial fibrillation is associated with local cardiac platelet activation and endothelial dysfunction.
    Akar JG; Jeske W; Wilber DJ
    J Am Coll Cardiol; 2008 May; 51(18):1790-3. PubMed ID: 18452786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients at high risk with atrial fibrillation: a prospective and serial follow-up during 12 months with transesophageal echocardiography and cerebral magnetic resonance imaging.
    Bernhardt P; Schmidt H; Hammerstingl C; Lüderitz B; Omran H
    J Am Soc Echocardiogr; 2005 Sep; 18(9):919-24. PubMed ID: 16153514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers.
    Capucci A; Santini M; Padeletti L; Gulizia M; Botto G; Boriani G; Ricci R; Favale S; Zolezzi F; Di Belardino N; Molon G; Drago F; Villani GQ; Mazzini E; Vimercati M; Grammatico A;
    J Am Coll Cardiol; 2005 Nov; 46(10):1913-20. PubMed ID: 16286180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and echocardiographic markers of mortality risk in patients with atrial fibrillation.
    Khumri TM; Idupulapati M; Rader VJ; Nayyar S; Stoner CN; Main ML
    Am J Cardiol; 2007 Jun; 99(12):1733-6. PubMed ID: 17560884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Predictive value of coagulative molecular markers for thromboembolism in patients with nonvalvular atrial fibrillation: prospective five-year follow-up study].
    Enta K; Iwade K; Aosaki M; Uchida T; Kasanuki H
    J Cardiol; 2004 Dec; 44(6):223-32. PubMed ID: 15638220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and risk factors of atrial fibrillation in preterminal inpatients aged 60 years and over.
    Yang JF; Liu B; Liu DG; Luo Y; Fang F
    Chin Med J (Engl); 2008 Oct; 121(20):2046-9. PubMed ID: 19080273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the endogenous coagulation system in patients with atrial flutter: relationship to echocardiographic markers of thromboembolic risk.
    Kamath GS; Herweg B; Cotiga D; Pierce W; Cohen AJ; Chaudhry FA; Drejka ML; Steinberg JS
    Cardiol J; 2010; 17(4):390-6. PubMed ID: 20690096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitral regurgitation reduces systemic coagulation activity in patients with rheumatic heart disease.
    Cevik C; Otahbachi M; Nugent K; Ozkan M
    J Heart Valve Dis; 2009 May; 18(3):278-83. PubMed ID: 19557983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Predictive factors of atrial fibrillation in mitral stenosis. Clinical and echocardiographic study].
    Khatouri A; Elyounassi B; Kendoussi M; Moyoupa C; Fall PD; Bahji M; Nazzi M; Hamani A
    Ann Cardiol Angeiol (Paris); 1999 Oct; 48(8):569-73. PubMed ID: 12555462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of atrial fibrillation: a persistent dilemma].
    Corbalán R
    Rev Med Chil; 1998 Jun; 126(6):605-7. PubMed ID: 9778866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy.
    Hohnloser SH; Pajitnev D; Pogue J; Healey JS; Pfeffer MA; Yusuf S; Connolly SJ;
    J Am Coll Cardiol; 2007 Nov; 50(22):2156-61. PubMed ID: 18036454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Transesophageal echocardiographic findings of cortical and perforating infarctions in patients with atrial fibrillation].
    Shinokawa N; Hirai T; Takashima S; Obata Y; Hiraoka Y; Kameyama T; Asanoi H; Inoue H
    J Cardiol; 1997; 29 Suppl 2():43-8. PubMed ID: 9211102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced dispersion of atrial refractoriness as an electrophysiological substrate for vulnerability to atrial fibrillation in patients with paroxysmal atrial fibrillation.
    Oliveira MM; da Silva N; Timóteo AT; Feliciano J; de Sousa L; Santos S; Marques F; Ferreira R
    Rev Port Cardiol; 2007; 26(7-8):691-702. PubMed ID: 17939579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: results from the Canadian Registry of Atrial Fibrillation.
    Kerr CR; Humphries KH; Talajic M; Klein GJ; Connolly SJ; Green M; Boone J; Sheldon R; Dorian P; Newman D
    Am Heart J; 2005 Mar; 149(3):489-96. PubMed ID: 15864238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.